Elevance Health: BofA Global Research raises price objective to $500.00 from $480.00
ELV•BofA Global Research raised its price objective for Elevance Health to $500.00 from $480.00.
Related News
Reborn Coffee enters supply agreement with Visvita for aloe vera beverages
REBN•
Allegion tops Q3 revenue and profit estimates, lifts outlook
ALLE•
Musk’s public endorsement of SpaceX-Tesla deal may throw a wrench in talks
SPCX•
Wabtec: Citigroup cuts target price to $334 from $338
WAB•
Investors see risk from US midterms to AI trade as data center backlash builds
QQQ•